CHM and Parkinson disease: Compared to conventional treatment, CHM paratherapy significantly improved UPDRS I–IV total summed score (WMD −6.09, 95% CI −8.08 to −4.10; Z = 6.00 (P < 0.001)), suggesting that CHM paratherapy could contribute to improving symptoms of PD (Table 8).